MONTVALE, N.J., June 6 /PRNewswire-FirstCall/ -- Memory Pharmaceuticals
Corp. (Nasdaq: MEMY) today announced that David A. Lowe, Ph.D., Chief
Scientific Officer, will provide a company update at the 6th Annual Needham &
Company Biotechnology & Medical Technology Conference on Wednesday, June 13,
2007, at 4:00 p.m. ET. The conference is being held at The New York Palace
Hotel in New York City.
Interested parties may access the live webcast of the presentation by
visiting the "Investors" section of Memory Pharmaceuticals' website at
http://www.memorypharma.com. Archived versions of the webcast will be
available at the same location for one week following the presentation.
About the Company
Memory Pharmaceuticals Corp., a biopharmaceutical company, is focused on
developing innovative drugs for the treatment of debilitating CNS disorders
such as Alzheimer's disease, schizophrenia, depression and bipolar disorder.
For additional information, please visit our website at
http://www.memorypharma.com.
SOURCE Memory Pharmaceuticals Corp.
-0- 06/06/2007
/CONTACT: Jzaneen Lalani, General Counsel of Memory Pharmaceuticals
Corp., +1-201-802-7249; or Laura Perry of Stern Investor Relations, Inc. for
Memory Pharmaceuticals Corp., +1-212-362-1200/
/Web site: http://www.memorypharma.com/
(MEMY)
CO: Memory Pharmaceuticals Corp.
ST: New Jersey
IN: HEA MTC
SU: TDS
MC
-- NYW133 --
6833 06/06/2007 17:06 EDT http://www.prnewswire.com
